Curcumin modulates cell type-specific miRNA networks to induce cytotoxicity in ovarian cancer cells

Febina Ravindran1, Anisha Mhatre1, Jinsha Koroth1

  • 1Institute of Bioinformatics and Applied Biotechnology, Electronic city phase 1, Bangalore, India.

Life Sciences
|December 12, 2023
PubMed
Abstract

Insights

Curcumin

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Cancer Research

Background:

  • Curcumin, a natural compound from Curcuma longa, possesses potential anti-cancer properties.
  • Ovarian cancer exhibits complex molecular heterogeneity, necessitating targeted therapeutic strategies.
  • Epigenetic modifications play a crucial role in ovarian cancer development and progression.

Purpose of the Study:

  • To elucidate the epigenetic mechanisms by which curcumin induces cytotoxicity in distinct ovarian cancer cell lines (PA1 and A2780).
  • To identify curcumin-modulated microRNA (miRNA)-mRNA regulatory networks involved in ovarian cancer cell death pathways.

Main Methods:

  • Integrated mRNA-miRNA sequencing to map regulatory networks.
  • Quantitative PCR (qPCR) and Western blotting for gene and protein expression validation.
  • Bioinformatic analysis using oncomiRdb and TCGA datasets.
  • Dual luciferase assay to confirm specific miRNA-target interactions.

Main Results:

  • Curcumin induced cell-type specific miRNA expression changes, inversely correlating with target genes involved in apoptosis, autophagy, and stemness.
  • Specific miRNAs (e.g., miR-335-5p, miR-32a, miR-1285) and their targets (e.g., ATG5, OCT4, PTEN, P53) were modulated differently in PA1 and A2780 cells.
  • Curcumin demonstrated cisplatin-sensitizing effects, impaired epithelial-to-mesenchymal transition (EMT), and regulated the miR-199a-5p/DDR1 axis, reducing collagen deposition.

Conclusions:

  • Curcumin's cytotoxic effects in ovarian cancer are mediated by distinct, cell-specific miRNA regulatory networks.
  • These findings highlight curcumin's potential as a therapeutic agent by targeting multiple cellular pathways.
  • The study establishes a molecular basis for curcumin's efficacy in ovarian cancer treatment.